Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. (Record no. 6372654)

MARC details
000 -LEADER
fixed length control field 01515 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512211753.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198406s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0003-990X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1001/archpsyc.1984.01790160106014
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Levy, M I
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19840608
245 00 - TITLE STATEMENT
Title Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Archives of general psychiatry
Date of publication, distribution, etc. May 1984
300 ## - PHYSICAL DESCRIPTION
Extent 520-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apomorphine
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dyskinesia, Drug-Induced
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Growth Hormone
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Homovanillic Acid
General subdivision cerebrospinal fluid
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Placebos
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prolactin
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psychiatric Status Rating Scales
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Dopamine
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenic Psychology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, B M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mohs, R C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kendler, K S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mathé, A A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trigos, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Horvath, T B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, K L
773 0# - HOST ITEM ENTRY
Title Archives of general psychiatry
Related parts vol. 41
-- no. 5
-- p. 520-4
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1001/archpsyc.1984.01790160106014">https://doi.org/10.1001/archpsyc.1984.01790160106014</a>
Public note Available from publisher's website

No items available.